Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |